Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions
Nadav Modlin,Michael Creed,Maria Sarang,Carolina Maggio,James Rucker,Victoria Williamson
DOI: https://doi.org/10.2147/ndt.s432537
IF: 2.989
2024-01-21
Neuropsychiatric Disease and Treatment
Abstract:Nadav Liam Modlin, 1 Michael Creed, 1, 2 Maria Sarang, 1 Carolina Maggio, 1 James J Rucker, 1, 2 Victoria Williamson 3, 4 1 The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK; 2 South London and Maudsley NHS Foundation Trust, Maudsley Hospital, Denmark Hill, London, SE5 8AZ, UK; 3 King's Centre for Military Health Research, King's College London, London, SE5 9RJ, UK; 4 Department of Experimental Psychology, Anna Watts Building, University of Oxford, Oxford, OX2 6 GG, UK Correspondence: Nadav Liam Modlin, The Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK, Email Introduction: Post-traumatic stress disorder (PTSD) is associated with significant patient burden. While pharmacotherapies and evidence-based psychotherapy interventions (EBPI) are effective, studies consistently highlight inadequate outcomes and high treatment dropout. Psychedelic therapy (PT) has shown preliminary promise across difficult-to-treat conditions, including MDMA-assisted therapy for PTSD, however trials of classical psychedelics in PTSD are lacking. Understanding patients' experiences of EBPI could help promote safety in PT. Aim: To systematically review qualitative research on patients' subjective experience of EBPI for PTSD, and of PT, and examine areas of overlap and divergence between them. Methods: Systematic literature searches for studies published between 2010 and 2023 were conducted on OVID, PubMed, Web of Science, and PsycInfo. Included were original studies in English that presented qualitative data of patient experiences of EBPI in PTSD, or PT for any indication. Extracted data from included studies were analysed using thematic synthesis. Syntheses were completed separately for EBPI and PT, before similarities and differences between the therapies were identified. Results: 40 research articles were included for review: 26 studies on EBPI for PTSD, and 14 studies on PT. EBPI studied were CBT, EMDR, CPT and PE. Psychedelic compounds studied were psilocybin, ibogaine, LSD, MDMA and ketamine, for treatment of substance use disorders, anxiety relating to physical illness, depression, and PTSD. Core themes from patient experiences of EBPI: 1) patient burden in PTSD treatment; 2) readiness; 3) key mechanisms of change; 4) psychological safety and trust. Themes identified in the review of PT: 1) indirect trauma processing; 2) reorganisation of self-narratives via processes of relatedness and identification; 3) key treatment characteristics. Conclusion: This study suggests overlap between patients' experience of EBPI and PT in terms of key mechanisms of change, the importance of psychological safety and readiness to engage in treatment. Trauma-informed care paradigms and practices may improve safety and acceptability of PT research. Keywords: trauma, PTSD, psychotherapy, psychedelic therapy, qualitative, review Trauma exposure is associated with an increased risk for psychopathology 1–3 including post-traumatic stress disorder (PTSD), major depressive disorder (MDD) and dissociative disorders. PTSD, characterised by debilitating comorbid symptomatology and psychosocial dysfunction, is associated with significant individual and societal burden. 4,5 Pharmacotherapies (eg, paroxetine and sertraline) and evidence-based psychotherapy interventions (EBPI) for PTSD, such as prolonged exposure (PE) or trauma-focused cognitive behavioural therapy (TF-CBT), are considered effective. 6–8 Despite EBPIs effectiveness, studies consistently highlight difficulties, including inadequate treatment outcomes 9,10 and poor patient retention. 11 Psychological treatment of PTSD may be challenging and complex, 12 potentially due to the significant symptomatic and psychosocial burden patients endure (eg, perceived negative experiences related to the treatment across different domains, including emotional, relational, physical, systemic, and practical aspects). 13 Further, patients who find treatment ineffective and seek additional care are also at increased risk of re-traumatisation due to the need to repeatedly recount their traumatic experiences to providers. 14 In response to the unmet clinical need in PTSD 15, and difficult-to-treat mental-health conditions 16 , studies investigating psychedelic forms of therapy have shown promise in so-called "treatment-resistant" patients. 17–21 Psychedelic therapy (PT) is an umbrella term for interventions administering serotonergic hallucinogens such as 4- -Abstract Truncated-
psychiatry,clinical neurology